跳至主要内容
临床试验/CTRI/2025/03/082077
CTRI/2025/03/082077已完成不适用

A study to compare the effect of Bempedoic acid added to statin therapy vs statin monotherapy in lowering the remnant cholesterol in established Atherosclerotic cardiovascular disease(ASCVD) patients: A randomized controlled trial

Dr Ashwin J Dhas K S1 个研究点 分布在 1 个国家目标入组 88 人开始时间: 2025年3月15日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
88
试验地点
1
主要终点
To establish the effect of bempedoic acid in lowering the remnant cholesterol

研究概览

简要总结

STUDY JUSTIFICATION: •              Recent studies have shown that elevated levels of remnant cholesterol was associated with an increased risk of ASCVD

•              Bempedoic acid has been shown effectively lower ldl levels not controlled with high intensity statins alone.

•              This interventional study is being done to establish the effect of bempedoic acid in lowering the remant cholesterol level

STUDY DESIGN- An open label randomized controlled trial

SAMPLE SIZE:88 (44 in each group)

METHODOLOGY : •              Select patients fitting the inclusion criteria

•              Measure the lipid profile and calculate the remnant cholesterol levels(remnant cholesterol= total cholesterol – [LDL cholesterol+HDL cholesterol] at baseline.

•              Patients were randomized 1:1 to treatment with bempedoic acid (180 mg) once daily for 12 weeks in the intervention group

•              Remnant cholesterol in measured at day 0 and day 90

•              Apolipoprotein B is measured at day 0 and at day 90

•              HsCRP measured at day 0 and day 90

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • Patients with established ASCVD on statins 2)LDL cholesterol of more than 55 mg/dl.

排除标准

  • Patients without established ASCVD 2)Patients not on statins 3)Lactating breastfeeding mothers 4)LDL cholesterol of less than 55 mg/dl 5)patients already on bempedoic acid 6)Patients on other anti-lipidemic drugs other than statins.

结局指标

主要结局

To establish the effect of bempedoic acid in lowering the remnant cholesterol

时间窗: DAY 0 AND DAY 90

次要结局

  • To determine the effect of bempedoic acid on other components of lipid profile,Apolipoprotein B and HsCRP(DAY 0 AND DAY 90)

研究者

发起方
Dr Ashwin J Dhas K S
申办方类型
Other [Self funded]
责任方
Principal Investigator
主要研究者

Dr Ashwin J Dhas K S

SRM Medical College Hospital and Research Center

研究点 (1)

Loading locations...

相似试验